SAN DIEGO--(BUSINESS WIRE)--June 16, 2006--Hollis-Eden Pharmaceuticals, Inc. (NASDAQ:HEPH - News) announced today that it has filed a shelf registration statement with the Securities and Exchange Commission (SEC) that, upon being declared effective by the SEC, will allow Hollis-Eden to offer and sell from time to time an aggregate of up to $75 million of its common stock, warrants or a combination of these securities. The terms of any offering under the shelf registration statement will be established at the time of the offering. Proceeds from the sale of any securities will be used for the purposes described in a prospectus or prospectus supplement filed at the time of an offering.
